HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP

[1]  Anat Melamed,et al.  The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. , 2014, Blood.

[2]  Daniel J. Laydon,et al.  Quantification of HTLV-1 Clonality and TCR Diversity , 2014, PLoS Comput. Biol..

[3]  L. Willems,et al.  Massive Depletion of Bovine Leukemia Virus Proviral Clones Located in Genomic Transcriptionally Active Sites during Primary Infection , 2013, PLoS pathogens.

[4]  D. Laydon,et al.  Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo , 2013, PLoS pathogens.

[5]  D. Laydon,et al.  Genome-wide Determinants of Proviral Targeting, Clonal Abundance and Expression in Natural HTLV-1 Infection , 2013, PLoS pathogens.

[6]  C. Bangham,et al.  HTLV-1-infected T cells contain a single integrated provirus in natural infection. , 2012, Blood.

[7]  A. Gessain,et al.  Epidemiological Aspects and World Distribution of HTLV-1 Infection , 2012, Front. Microbio..

[8]  Y. Yamano,et al.  Clinical Pathophysiology of Human T-Lymphotropic Virus-Type 1-Associated Myelopathy/Tropical Spastic Paraparesis , 2012, Front. Microbio..

[9]  R. Mahieux,et al.  HTLV-1 and Innate Immunity , 2011, Viruses.

[10]  Aidan MacNamara,et al.  In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. , 2011, The Journal of infectious diseases.

[11]  F. Bushman,et al.  The host genomic environment of the provirus determines the abundance of HTLV-1–infected T-cell clones , 2011, Blood.

[12]  Aidan MacNamara,et al.  HLA Class I Binding of HBZ Determines Outcome in HTLV-1 Infection , 2010, PLoS pathogens.

[13]  M. Boxus,et al.  Mechanisms of HTLV-1 persistence and transformation , 2009, British Journal of Cancer.

[14]  M. Matsuoka,et al.  HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. , 2009, The Journal of general virology.

[15]  C. Bangham.  CTL quality and the control of human retroviral infections , 2009, European journal of immunology.

[16]  Kousuke Saito,et al.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) , 2009, Retrovirology.

[17]  Joshua Arnold,et al.  Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. , 2008, Blood.

[18]  Y. Ohara,et al.  Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. , 2008, Blood.

[19]  F. Bushman,et al.  HTLV-1 Integration into Transcriptionally Active Genomic Regions Is Associated with Proviral Expression and with HAM/TSP , 2008, PLoS pathogens.

[20]  M. Matsuoka,et al.  Erratum: HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells (Proceedings of the National Academy of Sciences of the United States of America (January 17, 2006) 3, 103 (720-725) DOI: 10.1073/pnas.0507631103) , 2006 .

[21]  Jun-ichirou Yasunaga,et al.  HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Jerzy K. Kulski,et al.  High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR–SSOP–Luminex method in the Japanese population , 2005, Immunogenetics.

[23]  Becca Asquith,et al.  A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. , 2005, The Journal of general virology.

[24]  S. Marshall,et al.  Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. , 2004, The Journal of infectious diseases.

[25]  O. Pybus,et al.  The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains. , 2003, Molecular biology and evolution.

[26]  K. Yamaguchi,et al.  5′-Long Terminal Repeat-Selective CpG Methylation of Latent Human T-Cell Leukemia Virus Type 1 Provirus In Vitro and In Vivo , 2002, Journal of Virology.

[27]  S. Izumo,et al.  Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. , 2001, Blood.

[28]  T. Waldmann,et al.  How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy/tropical spastic paraparesis? , 2000, AIDS research and human retroviruses.

[29]  R. Tedder,et al.  HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests , 2000, BMJ : British Medical Journal.

[30]  S. Izumo,et al.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. , 1999, Journal of neurovirology.

[31]  M. Nowak,et al.  HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Matsuoka,et al.  Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. , 1996, Blood.

[33]  J. Weber,et al.  Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax , 1995, Journal of virology.

[34]  H. Inoko,et al.  Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. , 1991, International immunology.

[35]  W. Blattner,et al.  Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Terrence S. Furey,et al.  The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..

[37]  R. Janssen,et al.  The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. , 1990, Journal of acquired immune deficiency syndromes.